title: Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
authors.forename: J
authors.initials: J
authors.lastname: O'Riordan
authors.forename: M
authors.initials: M
authors.lastname: Javed
authors.forename: C
authors.initials: C
authors.lastname: Doherty
authors.forename: M
authors.initials: M
authors.lastname: Hutchinson
mesh_terms: D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015377:Cilastatin / Q000009:adverse effects* / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D006801:Humans; D015378:Imipenem / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination